Source: Journal of Clinical Oncology. Conference titles: Annual Meeting Proccedings. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS, QUALIDADE DE VIDA
ABNT
BEATO, C. A. M. et al. Effecst of capecitabine (X) on quality of life (Qol) in patients (pts) with metastatic coloretal cancer (MCRC). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 10 nov. 2024. , 2004APA
Beato, C. A. M., Federico, M. H. H., Eyll, B. V., Cabral, S., Perdicaris, M., Skare, N. G., et al. (2004). Effecst of capecitabine (X) on quality of life (Qol) in patients (pts) with metastatic coloretal cancer (MCRC). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.NLM
Beato CAM, Federico MHH, Eyll BV, Cabral S, Perdicaris M, Skare NG, Lago S, Carvalho MP, Moura GL, Duarte RC. Effecst of capecitabine (X) on quality of life (Qol) in patients (pts) with metastatic coloretal cancer (MCRC). Journal of Clinical Oncology. 2004 ; 22( 14S):[citado 2024 nov. 10 ]Vancouver
Beato CAM, Federico MHH, Eyll BV, Cabral S, Perdicaris M, Skare NG, Lago S, Carvalho MP, Moura GL, Duarte RC. Effecst of capecitabine (X) on quality of life (Qol) in patients (pts) with metastatic coloretal cancer (MCRC). Journal of Clinical Oncology. 2004 ; 22( 14S):[citado 2024 nov. 10 ]